Gene Bio Medical

Gene Bio MedicalGene Bio Medical
Gene Bio Medical

Gene Bio Medical

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Website
DR 162017ActiveTel Aviv, Israel
Rate
Advertise here

About

Gene Bio Medical is dedicated to the research, development, manufacturing, and commercialization of high-precision, cost-effective diagnostic technologies. They offer a broad range of services including molecular diagnostics and drug detection, and market their own products such as COVID-19 and Influenza home tests. The company aims to improve human health and strengthen global disease response capabilities by bringing meaningful innovations to communities worldwide.
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Gene Bio Medical do?

Gene Bio Medical is dedicated to the research, development, manufacturing, and commercialization of high-precision, cost-effective diagnostic technologies. They offer a broad range of services including molecular diagnostics and drug detection, and market their own products such as COVID-19 and Influenza home tests. The company aims to improve human health and strengthen global disease response capabilities by bringing meaningful innovations to communities worldwide.

How much funding has Gene Bio Medical raised?

Gene Bio Medical has raised a total of $10M in funding. The most recent round on record is Seed.

Where is Gene Bio Medical headquartered?

Gene Bio Medical is headquartered in Tel Aviv, Israel.

When was Gene Bio Medical founded?

Gene Bio Medical was founded in 2017.

What industry does Gene Bio Medical operate in?

Gene Bio Medical operates in Biotech, MedTech, HealthTech, Genomics, Drug Discovery, Clinical Trials.

What is Gene Bio Medical's revenue?

StartupHub estimates Gene Bio Medical's annual revenue at $427K (range $223K to $4.3M, 28% confidence), based on comparable companies in the sector.

What is Gene Bio Medical's valuation?

StartupHub estimates Gene Bio Medical's effective valuation at $36.7M (range $25.0M to $60.0M, 10% confidence), based on comparable companies in the sector.